Drug Trial Radar · NCT00041275
Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Last checked: Nov 20, 2026Latest source record: Sep 20, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Planned (sponsor's estimate)
Start
May 2002
Primary completion
Jun 2007
Study completion Aug 2011
Sponsor
- Lead sponsor
- National Medical Research Council (NMRC), SingaporeGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Jan 28, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using megestrol may fight liver cancer by blocking the uptake of estrogen. It is not yet known if megestrol is an effective treatment for liver cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of megestrol in treating patients who have liver cancer that cannot be removed by surgery.
Conditions
- Liver Cancer
Interventions
megestrol acetateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Survival measured weekly
Locations
12 sites in 10 countries. Site status is shown where the registry gives one.
Bangabandhu Sheikh Mujib Medical University
Dhaka, Bangladesh
Yangon General Hospital
Yangon, Burma
Rumah Sakit Sanglah
Denpasar, Bali, Indonesia
Auckland City Hospital
Auckland, New Zealand
Davao Doctors Hospital
Davao City, Philippines
National Cancer Centre - Singapore
Singapore, Singapore
Changi General Hospital
Singapore, Singapore
St. Vincent Hospital
Suwon, South Korea
Chang-Gung Memorial Hospital - Taipei
Taipei, Taiwan
Ramathibodi Hospital
Bangkok, Thailand
National Cancer Institute
Hà Nội, Vietnam
Cho Ray Hospital
Ho Chi Minh City, Vietnam
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.